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4, 7, 14, 21 and 42 days postop. qPCR was employed to determine
the expression patterns of BMPs and other molecules.
Gene expressions of BMP2, BMP4, BMP7, Nog, MMP9 and
MMP13 were distinctly lower in the delayed compared to the
standard healing group at several time points from day 14, whilst
no differential gene expression of Coll II and Coll X was found
between both groups. Among the BMPs, BMP7 showed the most
markedly differential expression. The ﬁrst evident difference in
BMP7 expression between both groups was found at day 14 sug-
gesting that exogen substitution in the context of a therapeutic
approach should be postponed. The differential expression pattern
of bothMMP9 andMMP13 suggests that there might be a failure in
endochondral ossiﬁcation in delayed bone healing.
Downregulation in gene expression of osteogenic BMPs and
cartilage matrix degrading MMPs may account for a considerable
delay of bone healing.
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Clinical application of tissue engineered vascular graft (TEVG)
still needs to overcome several limitations. Our aim was to eval-
uate a novel hybrid device able to simultaneously provide a spe-
ciﬁc microenviroment to allow cell differentiation and to function
as a drug delivery system.
We developed a multilayer hybrid construct with a middle
pivotal ﬁbronectin-collagen network and two functionalized Poly-
lactic acid (PLLA) layers on its inner and outer sides. The inner
side layer was realized as a drug delivery system releasing Heparin
(HEP) useful in the immediate management of the scaffold en-
graftment, and Erythropoietin (EPO), important in differentiation
and recruitment of endogenous stem cell populations.The outer one
was engrafted with TGF- for muscular differentiation.
PLLA/HEP-EPO nanocomposite scaffolds were prepared by
electrospinning. Polymer solutions containing 13%w/w PLLA
alone or 13%w/w PLLA with HEP and EPO solution were elec-
trospun (15 kV) forming a non-woven cloth. Membranes micro-
structure was evaluated by Scanning Electron Microscopy. After
sterilization scaffolds were seeded with human mesenchymal stem
cells and cell engraftment, viability, proliferation and differentia-
tion were evaluated by light and confocal microscopy.
Mean ﬁber diameter was 1.5 0.9 mm with a porosity favorable
to cell attachment and culture. Both HEP and EPO release showed
an initial burst within the ﬁrst 24 hrs and a further smoother pattern.
Microscopy was consistent with a good cell attachment and via-
bility with changes in cell morphology resembling to endothelial
phenotype.Detection of ki67þ cells conﬁrmed cell proliferation
and suggested the presence of a favourable mircorenviroment. A
shift towards CD31 positivity could be observed in the functio-
nalized scaffold.
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Mesenchymal stem cells (MSCs) are a widely used cell source in
tissue engineering and regenerative medicine because they can be
expanded and differentiated easily in vitro as well as in vivo. MSCs
can be obtained from a variety of tissues including adipose tissue.
Static cell culture with the aim of tissue engineering applications has
been proven to be disadvantageous since constructs grown in static
cell culture lack the mechanical stability native tissue exhibits.
Mechanical stimulation has therefore become a substantial tool in
tissue engineering to accustom cells to their future physically active
environment. Moreover, differentiation of stem and progenitor cells
has been proven to be supported by mechanical strain. In this work,
the effect of mechanical strain on the differentiation of a pre-
osteoblastic cell line and adipose tissue derived mesenchymal stem
cells was analysed. Nutrient supply especially on 3D scaffolds is
heterogeneous in static cell culture leading to reduced growth rates
or even death of the tissue on the scaffold. Thus, a speciﬁcally
customised bioreactor systems have been developed to control tissue
growth under dynamic culture conditions. In this work cultivation of
adMSC on 3D scaffolds under controlled and reproducible condi-
tions in a rotating bed system bioreactor is presented.
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This work aimed at studying the effects of dynamic culture con-
ditions and biomimetic coating on bone cells grown on nanoﬁber
meshes. In our previous work, biomimetic calcium phosphate
coated polycaprolactone nanoﬁbre meshes (BCP-NM) proved to
be more efﬁcient for supporting cell attachment and proliferation
under static conditions, when compared to polycaprolactone na-
noﬁbre meshe (PCL-NM). However, no studies on the inﬂuence of
bioreactors on the behaviour of cells cultivated on these materials
were developed so far. In fact, in vitro cultivation of constructs
using bioreactors which support efﬁcient nutrition of cells has ap-
peared as an important step toward the development of functional
grafts. In the current work, osteoblast-like cells were seeded on both
BCP-NM and PCL-NM. The formed constructs were cultured in a
rotating bioreactor (Synthecon, RCSS-1, USA), for different time
periods. Cell morphology and viability were assessed by confocal
ORAL PRESENTATIONS 723
microscopy. DNA and total protein quantiﬁcations were performed
accordingly. No signiﬁcant difference in cell proliferation was
observed in BCP-NM and PCL-NM constructs kept under dynamic
conditions when compared to the results obtained from static
studies. However, under dynamic conditions, total protein contents
were higher on BCP-NM constructs than in the uncoated ones.
Moreover, PCL-NM presented a higher number of dead cells than
BCP-NM. Obtained results point out that BCP-NM can support cell
growth under dynamic conditions. The vast potential of using BCP-
NM in applications related to bone tissue engineering was also
conﬁrmed.
Marie Curie Actions ‘‘Alea Jacta Est Training Fellowship’’ and
the European NoE EXPERTISSUES (NMP3-CT-2004-500283)
supported this work.
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We studied molecular dynamics and interactions of hemoglobin in
whole human red blood cells with Incoherent Elastic Neutron
Scattering and Small Angle Neutron Scattering. Thermal neutron
wavelengths and energies match atomic distances and atomic
thermal motions and allow their study in biological material
without damage. Protein dynamics were measured on time scales
of around 100ps which reﬂects protein side chain motions and long
time self diffusion of the whole protein.
We could show that there occurs a transition of hemoglobin
dynamics at human body temperature of 378C in cells and solution.
The measurements show that there is a break in the long term self
diffusion coefﬁcient at human body temperature. Complementary
from our interaction studies, we found that hemoglobin start
forming aggregated clusters at human body temperature.
(OP 91) Educational Aspects of Tissue Engineering: an In-
dustrial Perspective
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Tissue engineering is a branch of regenerative medicine that at-
tempts to convert insights from biomedical research into novel
therapies composed of cells, growth factors and/or biocompatible
structural materials. It aims to (i) repair, rather than replace dam-
aged tissues; (ii) postpone radical surgery; and (iii) stimulate en-
dogenous healing responses.
Society’s need for these new clinical approaches, (e.g. biological
therapies for cartilage repair), is indisputable and growing in line
with the aging population. Unfortunately, the commercial and
clinical success of tissue engineering has been poor to date because
the early innovators failed to appreciate the need to resolve all the
scientiﬁc, clinical, regulatory, commercial and logistical issues
involved in bringing a complex and unfamiliar therapy from
‘bench to bedside’.
Educators should therefore emphasise the multidisciplinary na-
ture of regenerative medicine to students. They should stress that in
order to be successful a new productmust simultaneously resolve all
the problems associated with its introduction (e.g. (i) deﬁnition of
clinical need; (ii) cell/molecular biology of the product; (iii) struc-
tural materials and biomechanics; (iv) scale-up and production; (v)
patents and IPR; (vi) regulatory approval and quality control; (vii)
distribution, inventory control and logistics; (viii) immunology and
graft integration; (ix) patient selection and adoption into clinical
practice; (x) proof of cost-effectiveness and re-imbursement; and
(xi) time to market and return on investors capital). Curricula,
should encompass these topics and the management approaches
(e.g. open innovation) required to build and maintain the multidis-
ciplinary teams needed to develop regenerative medicine.
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Everyone recognises that tissue engineering is a rapidly emerging,
multidisciplinary subject that, so far, is not grounded in traditional
academic courses. A multitude of departments, institutes and
centres concerned with tissue engineering have emerged in Uni-
versities throughout the world, but almost wholly being research or
clinically oriented. This has been inevitable and, as with any
emerging subject, is has been very sensible to identify its bound-
aries before constructing educational courses. The time is now
coming, however, where there is a role for new courses, in order to
provide for this education.
The subject of biomaterials provides an example of how this
could be done since 40 years ago this subject was similarly in its
infancy. We have witnessed the introduction of courses at under-
graduate and postgraduate levels, some based in medical schools
and others in engineering schools. We cannot pretend that we have
always got this right and it is no means obvious that either the
industrial or clinical end-users of the student output have fully
beneﬁted. The most obvious question has been whether it is pos-
sible or necessary to train ‘biomaterials scientists’ or for students to
follow a major relevant discipline, for example materials science,
cell biology or mechanical engineering, perhaps to PhD level, and
then to develop the skills and knowledge for the transition into
biomaterials science.
It is essential that the ﬁeld of tissue engineering learns these
lessons; this presentation will explore the options.
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